Indication
Intrahepatic
5 clinical trials
8 products
Clinical trial
Multicenter Comparative Randomized Study to Assess Safety and Efficacy and Select the Optimal Dosage Regimen of REMAXA®, Enteric-coated Tablets, in Comparison With REMAXOL®, Solution for Infusions, in Patients With Intrahepatic Cholestasis Caused by Chronic Diffuse Liver DiseasesStatus: Recruiting, Estimated PCD: 2025-05-01
Product
RemaxolProduct
RemaxaProduct
PlaceboClinical trial
A Phase I/IIA Study of ABC294640 Alone and in Combination With Hydroxychloroquine Sulfate in the Treatment of Patients With Advanced, Unresectable Intra-hepatic, Perihilar and Extra-Hepatic CholangiocarcinomaStatus: Completed, Estimated PCD: 2022-06-21
Product
ABC294640Product
HydroxychloroquineClinical trial
Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative TreatmentStatus: Recruiting, Estimated PCD: 2025-07-31
Product
ColchicineClinical trial
PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment: a Single-arm, Phase II Clinical StudyStatus: Recruiting, Estimated PCD: 2023-09-01
Clinical trial
Jian-She Wang of Children's Hospital of Fudan UniversityStatus: Withdrawn, Estimated PCD: 2023-02-08
Product
4-Phenylbutyrate